Figures & data
Figure 1 Overview of methodology.
Table 1 Definition of terms
Figure 2 Age-groups of study population (years, n=200).
Table 2 Demographic characteristics of study population (n=200)
Table 3 Clinical characteristics of study population (n=200)
Figure 3 Drug categories used in patients (n=200).
Table 4 DMARDs commonly used in RA patients (n=200)Table Footnotea
Figure 4 Classes of concurrent medications (n=200).
Abbreviations: ARBs, angiotensin-receptor blockers; CCBs, calcium-channel blockers.
Figure 5 Drug-related problems (n=289).
Table 5 Adverse reactions (n=289)
Table 6 Drug-choice problems (n=289)
Table 7 Dosing problems (n=289)
Table 8 Drug-use problems (n=289)
Figure 6 Drug pairs associated with drug interactions (n=97).
Table 9 Drug interactions (n=289)
Table 10 Other problems (n=289)
Table 11 Causes of drug-related problems (n=289)
Table 12 Factors associated with the occurrence of drug-related problems (n=200)
Table 13 Factors associated with adverse reactions and drug-choice problems
Table 14 Factors associated with dosing problems and drug-use problems
Table 15 Factors associated with drug interactions and other problems